
5.39BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US07782B1044
CUSIP
07782B104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
18.99
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.84
Wall Street Target Price
233.00
EPS Estimate Current Year
-2.81
EPS Estimate Next Year
-0.22
EPS Estimate Current Quarter
-0.7688
EPS Estimate Next Quarter
-0.9038
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-132,392,000
Profit Margin
0.00%
Return On Assets TTM
-15.46%
Return On Equity TTM
-21.23%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-2.84
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
312
Price Sales TTM
0
Price Book MRQ
7.9763
Enterprise Value Revenue
0
Enterprise Value EBITDA
-35
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%